What Will It Take for Novavax Stock to Rebound?
- Oops!Something went wrong.Please try again later.
- NVAX
Novavax (NASDAQ: NVAX) stock has plunged in recent weeks despite the company reporting several positive developments for its COVID-19 vaccine. In this Motley Fool Live video recorded on Jan. 5, Fool contributors Keith Speights and Brian Orelli discuss what it might take for Novavax to rebound. Novavax has won European authorization for its COVID-19 vaccine.